department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

CStone Pharmaceuticals Co Ltd · pharmadog

PUBLIC COMPANY

CStone Pharmaceuticals Co Ltd

updated 1mo ago

community read0 votes

pipeline

3

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

2Phase 21Phase 3

Hepatocellular Carcinoma

Diffuse Large B-Cell Lymphoma

Natural Killer Cell Lymphomas

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view CStone Pharmaceuticals Co Ltd jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Oncology3 DLBCL1

mentioned in

0news items

entity-linker matched

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase2A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Canceractive not recruitingn=70
phase2A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumorsrecruitingn=660
—Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real Worldcompletedn=61
phase3Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphomanot yet recruitingn=150
phase3A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinomaactive not recruitingn=534
phase1A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomasrecruitingn=480
phase3A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Canceractive not recruitingn=479
phase1A Study of CS1001 in Subjects with Advanced Solid Tumorscompletedn=24

more trials →